,48 The estimates of the equivalent Lp(a) reduction ranged from a 65.7 mg/dL affording ∼22% relative risk reduction,48 to 101.5 mg/dL affording ∼24% CHD relative risk reduction.47 The gene discussed is LPA; the disease is coronary artery disorder.